Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing ...

Researchers studied the prevalence of proliferative endometrial disorders in women with adenomyosis and evaluated the association between adenomyosis and each lesion type.

A sequential doublet chemotherapy regimen in patients (pts) with advanced endometrial adenocarcinoma (EC) and gynecological mixed müllerian tumors (MMT). Maintaining activity with tolerability? No ...

Please provide your email address to receive an email when new articles are posted on . Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with ...

Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...

Tamoxifen treatment for premenopausal women with breast cancer is independently associated with an increased risk of endometrial cancer and other uterine diseases, according to findings from a large ...

"Endometrial hyperplasia and cancer are highly affected by obesity and lifestyle factors. Focusing on these factors in diverse communities will lead to our better understanding of these disparities.